Mepiprazole
Anxiolytic drug
Mepiprazole | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Mepiprazole is a pharmacological compound that was developed as an anxiolytic drug. It belongs to the class of imidazole derivatives and has been studied for its potential effects on anxiety and related disorders.
Chemical Structure
Mepiprazole is chemically known as 4-methyl-2-(phenylmethyl)-1H-imidazole. The structure consists of an imidazole ring, which is a five-membered ring containing two nitrogen atoms, with a methyl group and a phenylmethyl group attached. This structure is significant as it influences the drug's pharmacological properties and its interaction with biological targets.
Pharmacology
Mepiprazole acts primarily as an anxiolytic, meaning it is used to reduce anxiety. The exact mechanism of action is not fully understood, but it is believed to involve modulation of neurotransmitter systems in the brain, particularly those involving serotonin and dopamine. These neurotransmitters play a crucial role in mood regulation and anxiety.
Clinical Use
Mepiprazole was investigated for its potential use in treating anxiety disorders. However, it is not widely used in clinical practice today. The development of newer anxiolytic drugs with more favorable safety profiles and efficacy has overshadowed its use.
Side Effects
As with many anxiolytic drugs, mepiprazole may cause side effects. Common side effects include drowsiness, dizziness, and nausea. In some cases, more severe side effects such as allergic reactions or cardiovascular issues may occur.
Research and Development
Research into mepiprazole has provided insights into the development of anxiolytic drugs and the role of imidazole derivatives in pharmacology. Although it is not a major drug in current therapeutic use, it has contributed to the understanding of anxiety treatment.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD